Editor2026-01-16T11:49:25+00:00Modella AI Announces Acquisition by AstraZeneca to Advance AI-Driven Oncology R&D at Global ScaleEditor2026-01-16T11:49:25+00:00January 13, 2026|
Editor2025-09-17T09:36:07+00:00Modella AI and Techcyte Announce a Research Collaboration with Modella AI’s State-of-the-Art Agentic and Generative AI-Powered Diagnostic Pathology PlatformEditor2025-09-17T09:36:07+00:00August 15, 2025|
Editor2025-10-01T13:27:09+00:00Modella AI and illumiSonics Announce Successful Research Compatibility Between Virtual H&E Imaging and Generative AI-Powered Pathology Diagnostic Platform ShareEditor2025-10-01T13:27:09+00:00July 29, 2025|
Editor2025-07-17T12:52:56+00:00Modella AI Announces Agreement to Accelerate AI-Driven Oncology Clinical DevelopmentEditor2025-07-17T12:52:56+00:00July 10, 2025|
admin@pathologynews.com2025-01-28T15:00:50+00:00Modella AI’s Generative AI Co-Pilot PathChat Receives FDA Breakthrough Device Designationadmin@pathologynews.com2025-01-28T15:00:50+00:00January 28, 2025|
admin@pathologynews.com2024-08-01T20:16:45+00:00Modella AI Emerges from Stealth with Breakthrough Multimodal and Generative AI Copilots for Pathologyadmin@pathologynews.com2024-08-01T20:16:45+00:00August 1, 2024|
Reviews
There are no reviews yet.